Bioventus Inc. (BVS)
NASDAQ · Healthcare
Bioventus Inc. annual/quarterly shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bioventus Inc. shareholder equity for the quarter ending December 31, 2025 were 184.1M, a 24.45% increase year-over-year.
- Bioventus Inc. shareholder equity for 2025 were 184.1M, a 24.45% increase from 2024.
- Bioventus Inc. shareholder equity for 2024 were 147.9M, a 14.78% decrease from 2023.
- Bioventus Inc. shareholder equity for 2023 were 173.6M, a 46.63% decrease from 2022.
- Bioventus Inc. shareholder equity for 2022 were 325.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bioventus Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $184 |
| 2024 | $148 |
| 2023 | $174 |
| 2022 | $325 |
| 2021 | $459 |
| Bioventus Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $184 |
| 2024-12-31 | $148 |
| 2023-12-31 | $174 |
| 2022-12-31 | $325 |
| 2021-12-31 | $459 |
Bioventus Inc. Shareholder Equity — FAQ
Bioventus Inc. (BVS) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BVS's shareholder equity history?
The chart and table above show Bioventus Inc.'s shareholder equity by year and by quarter, including the growth rate.